What's Next: Seres Therapeutics's Earnings Preview
What's Next: Seres Therapeutics's Earnings Preview
New investors should note that it is sometimes not an earnings beat or miss that most affects the price of a stock, but the guidance (or forecast).Seres Therapeutics (NASDAQ:MCRB) is gearing up to announce its quarterly earnings on Wednesday, 2024-11-13. Here's a quick overview of what investors should know before the release.
seres therapeutics（納斯達克：MCRB）正準備在2024年11月13日（週三）公佈季度業績。在發佈之前，投資者應該知道以下內容的簡要概述。
Analysts are estimating that Seres Therapeutics will report an earnings per share (EPS) of $-0.24.
分析師們預計Seres Therapeutics將報告每股收益（EPS）爲-0.24美元。
Seres Therapeutics bulls will hope to hear the company announce they've not only beaten that estimate, but also to provide positive guidance, or forecasted growth, for the next quarter.
Seres Therapeutics的看多者希望聽到公司宣佈他們不僅擊敗了這一預估，而且還提供了積極的指引，或者預測下一季度的增長。
New investors should note that it is sometimes not an earnings beat or miss that most affects the price of a stock, but the guidance (or forecast).
新投資者應該注意，有時不是盈利與否影響股票價格最大，而是其提供的指導或預測。
Earnings History Snapshot
收益歷史快照
The company's EPS beat by $0.05 in the last quarter, leading to a 9.07% increase in the share price on the following day.
該公司上季度的每股收益超出了0.05美元，導致股價在隨後一天上漲了9.07%。
Here's a look at Seres Therapeutics's past performance and the resulting price change:
讓我們看一下Seres Therapeutics過去的表現以及隨之而來的價格變化：
| Quarter | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 |
|---|---|---|---|---|
| EPS Estimate | -0.27 | -0.34 | -0.50 | -0.50 |
| EPS Actual | -0.22 | -0.27 | -0.32 | -0.37 |
| Price Change % | 9.0% | 37.0% | -5.0% | 39.0% |
| 季度 | 2024年第二季度 | Q1 2024 | 2023年第四季度 | 2023年第三季度 |
|---|---|---|---|---|
| 每股收益預估值 | -0.27 | -0.34 | -0.50 | -0.50 |
| 每股收益實際值 | -0.22 | -0.27 | -0.32 | -0.37 |
| 價格變更% | 9.0% | 37.0% | -5.0% | 39.0% |
Market Performance of Seres Therapeutics's Stock
seres therapeutics股票的市場表現
Shares of Seres Therapeutics were trading at $0.6917 as of November 11. Over the last 52-week period, shares are down 46.78%. Given that these returns are generally negative, long-term shareholders are likely bearish going into this earnings release.
截至11月11日，seres therapeutics的股價爲0.6917美元。在過去的52週中，股價下跌了46.78%。考慮到這些回報通常爲負數，長期股東可能會在這份業績公佈前持看淡態度。
To track all earnings releases for Seres Therapeutics visit their earnings calendar on our site.
要追蹤seres therapeutics的所有業績發佈，請訪問我們網站上的業績日曆。
This article was generated by Benzinga's automated content engine and reviewed by an editor.
本文是由Benzinga的自動內容引擎生成，並由編輯審核。
譯文內容由第三人軟體翻譯。
